Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004847094 | SCV005485516 | uncertain significance | not specified | 2024-12-10 | criteria provided, single submitter | clinical testing | The c.499A>C (p.K167Q) alteration is located in exon 3 (coding exon 3) of the RAET1L gene. This alteration results from a A to C substitution at nucleotide position 499, causing the lysine (K) at amino acid position 167 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |